Am J Obstet Gynecol. 2015 Dec;213(6):753-4. doi: 10.1016/j.ajog.2015.09.077. Epub 2015 Oct 14.
The purpose of this statement is to clarify that the Society for Maternal-Fetal Medicine (SMFM) does not recommend that cell-free DNA aneuploidy screening be offered to all pregnant women, nor does it suggest a requirement for insurance coverage for cell-free DNA screening in women at low risk of aneuploidy. However, SMFM believes, due to the ethics of patient autonomy, that the option should be available to women who request additional testing beyond what is currently recommended by professional societies.
本声明的目的是澄清,母胎医学协会(SMFM)不建议对所有孕妇进行游离DNA非整倍体筛查,也不建议对非整倍体低风险女性的游离DNA筛查提供保险覆盖要求。然而,SMFM认为,出于患者自主伦理的考虑,对于那些要求进行超出专业协会目前建议的额外检测的女性,应该提供这一选择。